SPU [SkyPeople Fruit Juice] 10-Q:

[] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Hongke Xue, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of SkyPeople Fruit Juice, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Xin Ma, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of SkyPeople Fruit Juice, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period presented therein. August 14, 2014 Hongke Xue EX-32.1 4 f10q0614ex32i_skypeople.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period presented therein. August 14, 2014 Xin Ma Principal Financial Officer and EX-32.2 5 f10q0614ex32ii_skypeople.htm CERTIFICATION]

BSPM [Biostar Pharmaceuticals] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x June 30, 2014 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Qinghua Liu, Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]

By | 2016-03-28T18:25:04+00:00 August 14th, 2014|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

CPGI [China Shengda Packaging] 8-K: (Original Filing)

[CHINA SHENGDA PACKAGING GROUP INC. Agreement Company Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required of] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 14, 2014 (August 9, 2014) CHINA SHENGDA PACKAGING GROUP INC. Nevada 333-148232 26-1559574 (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) No. 2 Beitang Road Xiaoshan Economic and Technological Development Zone Hangzhou, Zhejiang Province 311215 People's Republic of China (86) 571-82838805 ________________________________________________ (Former]

By | 2016-03-31T04:26:26+00:00 August 14th, 2014|Categories: Chinese Stocks, CPGI, SEC Original|Tags: , , , , , |0 Comments

THTI [THT Heat Transfer Technology] 10-Q: (Original Filing)

[FORM 10 Q (Mark One) For the quarterly period ended: June 30, 2014 For the transition period from ____________to _____________ THT HEAT TRANSFER TECHNOLOGY, INC. Nevada 20-5463509 (State or other jurisdiction of (I.R.S. Employer Identification No.) THT Industrial Park 86-434-3265241 _____________________________________________________ Yes [ X ] No [ ] Yes [ X ] No [ ] Large accelerated filer [ ]] [CERTIFICATIONS I, Guohong Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of THT Heat Transfer Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Zhigang Xu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of THT Heat Transfer Technology, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Guohong Zhao Chief Executive Officer] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. Zhigang Xu Interim Chief Financial Officer (Principal Financial Officer)]

By | 2016-03-15T14:28:14+00:00 August 14th, 2014|Categories: Chinese Stocks, SEC Original, THTI|Tags: , , , , , |0 Comments

OSN [Ossen Innovation] 6-K: (Original Filing)

[Ossen Innovation Receives NASDAQ Notification of Non-Compliance with Minimum Bid Price Rule In accordance with NASDAQ Marketplace Rule 5810(c)(3)(A), the Company has been provided with a period of 180 calendar days, or until February 9, 2015, to regain compliance with the Minimum Bid Price Rule. If at any time during this 180-day period the closing bid price of the Company's] [FORM 6-K OSSEN INNOVATION CO., LTD. 518 SHANGCHENG ROAD, FLOOR 17, SHANGHAI, 200120, PEOPLE’S REPUBLIC OF CHINA x ¨ Form 20-F ¨ x Yes OSSEN INNOVATION CO., LTD. Description 99.1 Press Release of Ossen Innovation Co., Ltd., dated August 13, 2014 6-K 1 v386780_6k.htm FORM 6-K]

BSPM [Biostar Pharmaceuticals] 10-Q: FORM 10-Q (Mark One) x June 30, 2014

[FORM 10-Q (Mark One) x June 30, 2014 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Qinghua Liu, Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]

By | 2016-03-28T18:26:22+00:00 August 14th, 2014|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

CPGI [China Shengda Packaging] 8-K: CHINA SHENGDA PACKAGING GROUP INC. Agreement Company Director

[CHINA SHENGDA PACKAGING GROUP INC. Agreement Company Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required of] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): August 14, 2014 (August 9, 2014) CHINA SHENGDA PACKAGING GROUP INC. Nevada 333-148232 26-1559574 (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) No. 2 Beitang Road Xiaoshan Economic and Technological Development Zone Hangzhou, Zhejiang Province 311215 People's Republic of China (86) 571-82838805 ________________________________________________ (Former]

By | 2016-03-31T04:27:28+00:00 August 14th, 2014|Categories: Chinese Stocks, CPGI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar